Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Natus Medical Inc (BABY) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Natus Medical Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 878526.
Total stock buying since 2014: $1,461,348.
Total stock sales since 2014: $73,010,539.
Total stock option exercises since 2014: $18,905,239.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 0 | $0 | 122,039 | $3,312,931 | 11,787 | $243,755 |
| 2020 | 0 | $0 | 1,200 | $21,636 | 0 | $0 |
| 2019 | 100 | $2,718 | 132,291 | $3,892,335 | 121,850 | $2,371,585 |
| 2018 | 0 | $0 | 309,923 | $10,514,213 | 242,078 | $2,804,354 |
| 2017 | 10,000 | $338,760 | 40,042 | $1,534,266 | 27,642 | $380,842 |
| 2016 | 30,000 | $1,119,870 | 57,610 | $2,195,149 | 37,264 | $618,254 |
| 2015 | 0 | $0 | 645,505 | $28,183,285 | 505,060 | $7,670,699 |
| 2014 | 0 | $0 | 465,623 | $23,356,724 | 451,133 | $4,815,750 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-12 | 0 | $0 | 11,787 | $272,043 | 11,787 | $243,755 |
| 2021-06 | 0 | $0 | 2,500 | $68,650 | 0 | $0 |
| 2021-05 | 0 | $0 | 107,752 | $2,972,238 | 0 | $0 |
| 2020-08 | 0 | $0 | 1,200 | $21,636 | 0 | $0 |
| 2019-12 | 0 | $0 | 6,684 | $210,813 | 7,600 | $171,000 |
| 2019-11 | 0 | $0 | 8,676 | $294,806 | 10,000 | $225,000 |
| 2019-10 | 0 | $0 | 14,000 | $469,980 | 14,000 | $315,000 |
| 2019-08 | 0 | $0 | 12,632 | $403,466 | 0 | $0 |
| 2019-07 | 0 | $0 | 20,000 | $622,800 | 20,000 | $450,000 |
| 2019-06 | 0 | $0 | 4,250 | $103,742 | 0 | $0 |
| 2019-05 | 0 | $0 | 23,015 | $600,054 | 16,000 | $229,440 |
| 2019-04 | 0 | $0 | 16,250 | $429,127 | 14,250 | $204,345 |
| 2019-03 | 100 | $2,718 | 8,304 | $233,827 | 0 | $0 |
| 2019-02 | 0 | $0 | 18,480 | $523,720 | 40,000 | $776,800 |
| 2018-11 | 0 | $0 | 24,750 | $844,015 | 0 | $0 |
| 2018-10 | 0 | $0 | 20,000 | $581,200 | 0 | $0 |
| 2018-08 | 0 | $0 | 55,600 | $2,050,310 | 39,345 | $570,367 |
| 2018-07 | 0 | $0 | 12,840 | $445,043 | 0 | $0 |
| 2018-05 | 0 | $0 | 32,733 | $1,114,945 | 37,733 | $470,137 |
| 2018-04 | 0 | $0 | 160,000 | $5,352,000 | 160,000 | $1,710,400 |
| 2018-03 | 0 | $0 | 4,000 | $126,700 | 5,000 | $53,450 |
| 2017-11 | 0 | $0 | 17,642 | $747,518 | 12,642 | $135,142 |
| 2017-09 | 0 | $0 | 4,400 | $154,748 | 0 | $0 |
| 2017-08 | 0 | $0 | 3,000 | $102,300 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-12-09 | Chung Dong Chune Christopher (Chief Medical Officer) | Sale | 11,787 | 23.08 | 272,043 |
| 2021-12-09 | Chung Dong Chune Christopher (Chief Medical Officer) | Option Ex | 11,787 | 20.68 | 243,755 |
| 2021-06-11 | Daskal Ilan | Sale | 2,500 | 27.46 | 68,650 |
| 2021-05-25 | Chung Dong Chune Christopher (VP of Medical Affairs) | Sale | 9,435 | 27.41 | 258,613 |
| 2021-05-24 | Chung Dong Chune Christopher (VP of Medical Affairs) | Sale | 20,000 | 27.11 | 542,200 |
| 2021-05-20 | Chung Dong Chune Christopher (VP of Medical Affairs) | Sale | 9,290 | 27.00 | 250,830 |
| 2021-05-19 | Chung Dong Chune Christopher (VP of Medical Affairs) | Sale | 6,367 | 26.54 | 168,980 |
| 2021-05-18 | Chung Dong Chune Christopher (VP of Medical Affairs) | Sale | 2,904 | 26.90 | 78,117 |
| 2021-05-14 | Chung Dong Chune Christopher (VP of Medical Affairs) | Sale | 21,927 | 28.31 | 620,753 |
| 2021-05-13 | Chung Dong Chune Christopher (VP of Medical Affairs) | Sale | 27,721 | 27.96 | 775,079 |
| 2021-05-12 | Chung Dong Chune Christopher (VP of Medical Affairs) | Sale | 10,108 | 27.47 | 277,666 |
| 2020-08-07 | Heine Lisa Wipperman | Sale | 1,200 | 18.03 | 21,636 |
| 2019-12-06 | Kennedy Jonathan (President and CEO) | Sale | 6,684 | 31.54 | 210,813 |
| 2019-12-06 | Kennedy Jonathan (President and CEO) | Option Ex | 7,600 | 22.50 | 171,000 |
| 2019-11-05 | Kennedy Jonathan (President and CEO) | Sale | 4,268 | 34.32 | 146,477 |
| 2019-11-05 | Kennedy Jonathan (President and CEO) | Option Ex | 5,000 | 22.50 | 112,500 |
| 2019-11-04 | Kennedy Jonathan (President and CEO) | Sale | 4,408 | 33.65 | 148,329 |
| 2019-11-04 | Kennedy Jonathan (President and CEO) | Option Ex | 5,000 | 22.50 | 112,500 |
| 2019-10-30 | Chung Dong Chune Christopher (VP of Medical Affairs) | Sale | 14,000 | 33.57 | 469,980 |
| 2019-10-30 | Chung Dong Chune Christopher (VP of Medical Affairs) | Option Ex | 14,000 | 22.50 | 315,000 |
| 2019-08-01 | Ludlum Ken | Sale | 12,632 | 31.94 | 403,466 |
| 2019-07-31 | Noll Austin Francis Iii (Executive VP and CCO) | Sale | 20,000 | 31.14 | 622,800 |
| 2019-07-31 | Noll Austin Francis Iii (Executive VP and CCO) | Option Ex | 20,000 | 22.50 | 450,000 |
| 2019-06-11 | Ludlum Ken | Sale | 4,250 | 24.41 | 103,742 |
| 2019-05-31 | Ludlum Ken | Sale | 6,000 | 24.84 | 149,040 |
| 2019-05-21 | Chung Dong Chune Christopher (VP of Medical Affairs) | Sale | 500 | 26.64 | 13,320 |
| 2019-05-17 | Chung Dong Chune Christopher (VP of Medical Affairs) | Sale | 3,000 | 26.28 | 78,840 |
| 2019-05-17 | Chung Dong Chune Christopher (VP of Medical Affairs) | Option Ex | 16,000 | 14.34 | 229,440 |
| 2019-05-10 | Ludlum Ken | Sale | 7,515 | 26.28 | 197,494 |
| 2019-05-02 | Gunst Robert A | Sale | 2,000 | 26.92 | 53,840 |
| 2019-05-01 | Gunst Robert A | Sale | 4,000 | 26.88 | 107,520 |
| 2019-04-30 | Noll Austin Francis Iii (Executive VP and CCO) | Sale | 14,250 | 26.43 | 376,627 |
| 2019-04-30 | Noll Austin Francis Iii (Executive VP and CCO) | Option Ex | 14,250 | 14.34 | 204,345 |
| 2019-04-30 | Gunst Robert A | Sale | 2,000 | 26.25 | 52,500 |
| 2019-03-07 | Heine Lisa Wipperman | Buy | 100 | 27.18 | 2,718 |
| 2019-03-04 | Gunst Robert A | Sale | 2,000 | 28.50 | 57,000 |
| 2019-03-01 | Gunst Robert A | Sale | 6,304 | 28.05 | 176,827 |
| 2019-02-25 | Gunst Robert A | Sale | 11,088 | 28.34 | 314,232 |
| 2019-02-22 | Gunst Robert A | Option Ex | 24,000 | 19.42 | 466,080 |
| 2018-11-29 | Ludlum Ken | Sale | 10,000 | 34.93 | 349,300 |
| 2018-11-19 | Gunst Robert A | Sale | 14,750 | 33.54 | 494,715 |
| 2018-10-26 | Ludlum Ken | Sale | 20,000 | 29.06 | 581,200 |
| 2018-08-30 | Kennedy Jonathan (President and CEO) | Sale | 4,072 | 36.54 | 148,790 |
| 2018-08-29 | Kennedy Jonathan (President and CEO) | Sale | 43,528 | 36.91 | 1,606,400 |
| 2018-08-29 | Kennedy Jonathan (President and CEO) | Option Ex | 31,345 | 13.24 | 415,007 |
| 2018-08-02 | Ludlum Ken | Sale | 8,000 | 36.89 | 295,120 |
| 2018-08-02 | Ludlum Ken | Option Ex | 8,000 | 19.42 | 155,360 |
| 2018-07-31 | Gunst Robert A | Sale | 3,740 | 36.02 | 134,733 |
| 2018-07-27 | Gunst Robert A | Sale | 9,100 | 34.10 | 310,310 |
| 2018-05-16 | Moore William M | Sale | 8,000 | 35.91 | 287,280 |
| 2018-05-16 | Moore William M | Option Ex | 8,000 | 17.59 | 140,760 |
| 2018-05-09 | Noll Austin Francis Iii (VP/GM Neurology) | Sale | 9,375 | 33.70 | 315,937 |
| 2018-05-09 | Noll Austin Francis Iii (VP/GM Neurology) | Option Ex | 9,375 | 11.92 | 111,750 |
| 2018-05-07 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Sale | 15,358 | 33.32 | 511,728 |
| 2018-05-07 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Option Ex | 15,358 | 10.69 | 164,177 |
| 2018-05-02 | Gunst Robert A | Option Ex | 5,000 | 10.69 | 53,450 |
| 2018-04-30 | Hawkins James B (President and CEO) | Sale | 160,000 | 33.45 | 5,352,000 |
| 2018-04-30 | Hawkins James B (President and CEO) | Option Ex | 160,000 | 10.69 | 1,710,400 |
| 2018-03-02 | Ludlum Ken | Sale | 4,000 | 31.68 | 126,700 |
| 2018-03-02 | Ludlum Ken | Option Ex | 5,000 | 10.69 | 53,450 |
| 2017-11-13 | Moore William M | Sale | 5,000 | 41.01 | 205,050 |
| 2017-11-06 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Sale | 12,642 | 42.91 | 542,468 |
| 2017-11-06 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Option Ex | 12,642 | 10.69 | 135,142 |
| 2017-09-14 | Gunst Robert A | Sale | 4,400 | 35.17 | 154,748 |
| 2017-08-14 | Moore William M | Sale | 3,000 | 34.10 | 102,300 |
| 2017-06-15 | Hawkins James B (President and CEO) | Buy | 4,000 | 33.98 | 135,900 |
| 2017-05-31 | Hawkins James B (President and CEO) | Buy | 6,000 | 33.81 | 202,860 |
| 2017-05-25 | Engibous Doris | Sale | 5,000 | 32.68 | 163,400 |
| 2017-05-25 | Engibous Doris | Option Ex | 5,000 | 16.38 | 81,900 |
| 2017-03-10 | Moore William M | Option Ex | 5,000 | 16.38 | 81,900 |
| 2017-03-02 | Moore William M | Sale | 5,000 | 37.26 | 186,300 |
| 2017-02-09 | Gunst Robert A | Sale | 5,000 | 36.00 | 180,000 |
| 2017-02-09 | Gunst Robert A | Option Ex | 5,000 | 16.38 | 81,900 |
| 2016-12-16 | Hawkins James B (President and CEO) | Buy | 10,000 | 35.20 | 352,000 |
| 2016-10-27 | Hawkins James B (President and CEO) | Buy | 10,000 | 38.30 | 383,030 |
| 2016-10-25 | Kennedy Jonathan (Sr. VP, CFO) | Sale | 16,138 | 41.22 | 665,159 |
| 2016-10-25 | Kennedy Jonathan (Sr. VP, CFO) | Option Ex | 9,905 | 13.24 | 131,142 |
| 2016-10-24 | Kennedy Jonathan (Sr. VP, CFO) | Sale | 14,138 | 41.61 | 588,225 |
| 2016-10-24 | Kennedy Jonathan (Sr. VP, CFO) | Option Ex | 4,900 | 22.50 | 110,250 |
| 2016-10-24 | Gunst Robert A | Sale | 3,250 | 41.92 | 136,236 |
| 2016-09-28 | Hawkins James B (President and CEO) | Buy | 10,000 | 38.48 | 384,840 |
| 2016-04-26 | Gunst Robert A | Sale | 5,000 | 34.61 | 173,050 |
| 2016-04-26 | Gunst Robert A | Option Ex | 5,000 | 16.78 | 83,900 |
| 2016-04-26 | Moore William M | Option Ex | 5,000 | 16.78 | 83,900 |
| 2016-04-22 | Engibous Doris | Sale | 5,000 | 32.68 | 163,400 |
| 2016-04-22 | Engibous Doris | Option Ex | 5,000 | 16.78 | 83,900 |
| 2016-04-22 | Traverso Kenneth M (VP/GM Newborn Care) | Sale | 7,459 | 33.56 | 250,324 |
| 2016-04-22 | Traverso Kenneth M (VP/GM Newborn Care) | Option Ex | 7,459 | 16.78 | 125,162 |
| 2016-02-17 | Ludlum Ken | Sale | 117 | 33.00 | 3,861 |
| 2016-02-16 | Ludlum Ken | Sale | 6,508 | 33.02 | 214,894 |
| 2015-12-09 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Sale | 14,000 | 48.78 | 682,920 |
| 2015-12-09 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Option Ex | 14,000 | 10.69 | 149,660 |
| 2015-11-27 | Hawkins James B (President and CEO) | Sale | 43,408 | 49.17 | 2,134,371 |
| 2015-11-25 | Noll Austin Francis Iii (VP/GM Neurology) | Sale | 38,875 | 48.40 | 1,881,550 |
| 2015-11-25 | Noll Austin Francis Iii (VP/GM Neurology) | Option Ex | 38,875 | 13.13 | 510,428 |
| 2015-11-25 | Hawkins James B (President and CEO) | Sale | 14,103 | 48.86 | 689,072 |
| 2015-11-12 | Hawkins James B (President and CEO) | Sale | 26,758 | 47.32 | 1,266,188 |
| 2015-11-10 | Hawkins James B (President and CEO) | Sale | 15,731 | 48.12 | 756,975 |
| 2015-10-30 | Hawkins James B (President and CEO) | Sale | 37,649 | 45.53 | 1,714,158 |
| 2015-10-30 | Hawkins James B (President and CEO) | Option Ex | 37,649 | 16.38 | 616,690 |
| 2015-10-29 | Hawkins James B (President and CEO) | Sale | 6,162 | 45.89 | 282,774 |
| 2015-10-29 | Hawkins James B (President and CEO) | Option Ex | 6,162 | 16.38 | 100,933 |
| 2015-10-28 | Kennedy Jonathan (Sr. VP, CFO) | Sale | 18,462 | 45.70 | 843,713 |
| 2015-10-28 | Kennedy Jonathan (Sr. VP, CFO) | Option Ex | 18,462 | 17.87 | 329,915 |
| 2015-10-28 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Sale | 24,600 | 45.71 | 1,124,466 |
| 2015-10-28 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Option Ex | 24,600 | 16.38 | 402,948 |
| 2015-10-28 | Hawkins James B (President and CEO) | Sale | 56,189 | 45.89 | 2,578,513 |
| 2015-10-28 | Hawkins James B (President and CEO) | Option Ex | 56,189 | 16.38 | 920,375 |
| 2015-10-27 | Kennedy Jonathan (Sr. VP, CFO) | Sale | 10,496 | 45.75 | 480,192 |
| 2015-10-27 | Kennedy Jonathan (Sr. VP, CFO) | Option Ex | 10,496 | 13.24 | 138,967 |
| 2015-10-27 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Sale | 1,400 | 46.02 | 64,428 |
| 2015-10-27 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Option Ex | 1,400 | 16.38 | 22,932 |
| 2015-09-15 | Moore William M | Sale | 5,994 | 40.76 | 244,315 |
| 2015-09-14 | Moore William M | Sale | 4,000 | 40.27 | 161,080 |
| 2015-09-08 | Moore William M | Sale | 3,006 | 40.09 | 120,510 |
| 2015-08-18 | Moore William M | Sale | 3,000 | 45.62 | 136,860 |
| 2015-08-13 | Moore William M | Sale | 3,006 | 45.55 | 136,923 |
| 2015-08-12 | Moore William M | Sale | 994 | 45.54 | 45,266 |
| 2015-07-28 | Traverso Kenneth M (VP/GM Newborn Care) | Sale | 2,541 | 45.77 | 116,301 |
| 2015-07-28 | Traverso Kenneth M (VP/GM Newborn Care) | Option Ex | 2,541 | 16.78 | 42,637 |
| 2015-07-24 | Gunst Robert A | Sale | 4,000 | 45.30 | 181,200 |
| 2015-07-24 | Traverso Kenneth M (VP/GM Newborn Care) | Sale | 16,000 | 45.54 | 728,640 |
| 2015-07-24 | Traverso Kenneth M (VP/GM Newborn Care) | Option Ex | 16,000 | 16.78 | 268,480 |
| 2015-06-15 | Moore William M | Sale | 6,000 | 41.30 | 247,799 |
| 2015-06-08 | Hawkins James B (President and CEO) | Sale | 100,000 | 42.08 | 4,208,000 |
| 2015-06-08 | Hawkins James B (President and CEO) | Option Ex | 100,000 | 16.78 | 1,678,000 |
| 2015-06-03 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Sale | 26,000 | 41.01 | 1,066,260 |
| 2015-06-03 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Option Ex | 26,000 | 16.78 | 436,280 |
| 2015-05-28 | Moore William M | Sale | 6,000 | 38.29 | 229,740 |
| 2015-05-27 | Ludlum Ken | Sale | 7,500 | 36.57 | 274,275 |
| 2015-05-27 | Ludlum Ken | Option Ex | 7,500 | 14.63 | 109,725 |
| 2015-05-26 | Traverso Kenneth M (VP/GM Newborn Care) | Sale | 25,939 | 36.19 | 938,732 |
| 2015-05-26 | Traverso Kenneth M (VP/GM Newborn Care) | Option Ex | 25,939 | 10.38 | 269,246 |
| 2015-05-13 | Kennedy Jonathan (Sr. VP, CFO) | Sale | 11,459 | 36.25 | 415,388 |
| 2015-05-13 | Kennedy Jonathan (Sr. VP, CFO) | Option Ex | 30,186 | 24.75 | 746,952 |
| 2015-04-28 | Traverso Kenneth M (VP/GM Newborn Care) | Sale | 57,233 | 40.78 | 2,334,076 |
| 2015-04-28 | Traverso Kenneth M (VP/GM Newborn Care) | Option Ex | 34,061 | 10.03 | 341,631 |
| 2015-04-24 | Engibous Doris | Sale | 15,000 | 42.20 | 633,000 |
| 2015-04-24 | Engibous Doris | Option Ex | 15,000 | 10.38 | 155,700 |
| 2015-02-03 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Sale | 40,000 | 36.64 | 1,465,600 |
| 2015-02-03 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Option Ex | 40,000 | 10.73 | 429,200 |
| 2014-12-09 | Kennedy Jonathan (Sr. VP, CFO) | Sale | 45,833 | 35.67 | 1,634,863 |
| 2014-12-09 | Kennedy Jonathan (Sr. VP, CFO) | Option Ex | 45,833 | 13.24 | 606,828 |
| 2014-12-08 | Moore William M (Director) | Sale | 4,451 | 34.65 | 154,227 |
| 2014-12-05 | Moore William M (Director) | Sale | 561 | 34.65 | 19,438 |
| 2014-12-02 | Moore William M (Director) | Sale | 2,278 | 3,478.00 | 7,922,884 |
| 2014-11-04 | Hawkins James B (President & CEO) | Sale | 4,100 | 34.01 | 139,441 |
| 2014-11-04 | Hawkins James B (President & CEO) | Option Ex | 4,100 | 10.73 | 43,993 |
| 2014-10-30 | Gunst Robert A (Director) | Sale | 15,000 | 33.93 | 508,950 |
| 2014-10-30 | Gunst Robert A (Director) | Option Ex | 15,000 | 10.38 | 155,700 |
| 2014-10-28 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Sale | 10,479 | 33.33 | 349,265 |
| 2014-10-28 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Option Ex | 10,479 | 10.03 | 105,104 |
| 2014-10-28 | Hawkins James B (President & CEO) | Sale | 130,000 | 33.36 | 4,336,800 |
| 2014-10-28 | Hawkins James B (President & CEO) | Option Ex | 130,000 | 10.03 | 1,303,900 |
| 2014-10-27 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Sale | 39,521 | 33.09 | 1,307,749 |
| 2014-10-27 | Chung Dong Chune Christopher (Vice President Medical Affairs) | Option Ex | 39,521 | 10.03 | 396,395 |
| 2014-10-27 | Hawkins James B (President & CEO) | Sale | 71,600 | 33.24 | 2,379,984 |
| 2014-10-27 | Hawkins James B (President & CEO) | Option Ex | 71,600 | 10.38 | 743,208 |
| 2014-10-24 | Traverso Kenneth M (VP/GM Newborn Care) | Sale | 30,000 | 33.33 | 999,900 |
| 2014-10-24 | Traverso Kenneth M (VP/GM Newborn Care) | Option Ex | 30,000 | 10.73 | 321,900 |
| 2014-10-24 | Hawkins James B (President & CEO) | Sale | 64,300 | 33.70 | 2,151,559 |
| 2014-10-24 | Hawkins James B (President & CEO) | Option Ex | 64,300 | 10.38 | 654,938 |
| 2014-09-10 | Moore William M (Director) | Sale | 2,200 | 29.30 | 64,460 |
| 2014-09-08 | Moore William M (Director) | Sale | 5,000 | 29.17 | 145,850 |
| 2014-07-30 | Noll Austin Francis Iii (VP/GM Neurology) | Sale | 23,500 | 29.42 | 691,370 |
| 2014-07-30 | Noll Austin Francis Iii (VP/GM Neurology) | Option Ex | 23,500 | 11.92 | 280,120 |
| 2014-05-30 | Ludlum Ken (Director) | Sale | 2,500 | 24.77 | 61,925 |
| 2014-05-30 | Ludlum Ken (Director) | Option Ex | 2,500 | 20.09 | 50,225 |
Insider trading activities including stock purchases, stock sales, and option exercises of BABY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Natus Medical Inc (symbol BABY, CIK number 878526) see the Securities and Exchange Commission (SEC) website.